(Q46617240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Massimo Filippi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

M P Sormani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Comi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

447-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1178OA

10.1191/1352458505MS1178OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042228%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference